Imaging mass spectrometry: a molecular microscope for studying the role of lipids in Parkinson's disease

被引:0
|
作者
Vinata Vedam-Mai [1 ]
Jacob M.Samuel [2 ]
Boone M.Prentice [2 ]
机构
[1] Department of Neurology, University of Florida
[2] Department of Chemistry, University of Florida
关键词
D O I
暂无
中图分类号
R742.5 [震颤麻痹综合征];
学科分类号
1002 ;
摘要
Parkinson’s disease–A lipidopathy? The histopathological hallmark of Parkinson’s disease(PD) and dementia with Lewy bodies are inclusions enriched in α-synuclein(α-syn), known as Lewy bodies, which are not only composed of proteins, but also a core of lipid species. PD has been thus far principally thought of as a “proteinopathy” caused by the misfolding of α-syn. However,
引用
收藏
页码:1179 / 1180
页数:2
相关论文
共 50 条
  • [1] Imaging mass spectrometry: a molecular microscope for studying the role of lipids in Parkinson's disease
    Vedam-Mai, Vinata
    Samuel, Jacob M.
    Prentice, Boone M.
    NEURAL REGENERATION RESEARCH, 2024, 19 (06) : 1179 - 1180
  • [2] MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
    Hanrieder, Jorg
    Ljungdahl, Anna
    Andersson, Malin
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2012, (60):
  • [3] The Role of Lipids in Parkinson's Disease
    Xicoy, Helena
    Wieringa, Be
    Martens, Gerard J. M.
    CELLS, 2019, 8 (01)
  • [4] Micrometric molecular histology of lipids by mass spectrometry imaging
    Touboul, David
    Laprevote, Olivier
    Brunelle, Alain
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2011, 15 (05) : 725 - 732
  • [5] Molecular imaging of lipids in the human brain by mass spectrometry
    Yuki, Dai
    Zaima, Nobuhiro
    Sugiura, Yuki
    Akatsu, Hiroyasu
    Hashizume, Yosio
    Yamamoto, Takayuki
    Fujiwara, Masami
    Sugiyama, Keikichi
    Setou, Mitsutoshi
    NEUROSCIENCE RESEARCH, 2010, 68 : E333 - E333
  • [6] Dynorphins in experimental Parkinson’s disease revealed by imaging mass spectrometry
    Georgy Bakalkin
    Andreas Zimmer
    Malin Andersson
    Anna Karlsson
    Jörg Hanrieder
    Maria Fälth
    Jonas Bergquist
    Pharmacological Reports, 2011, 63 : 207 - 207
  • [7] Dynorphins in experimental Parkinson's disease revealed by imaging mass spectrometry
    Andersson, Malin
    Karlsson, Anna
    Hanrieder, Jorg
    Faelth, Maria
    Bergquist, Jonas
    PHARMACOLOGICAL REPORTS, 2011, 63 (01) : 207 - 207
  • [8] MOLECULAR IMAGING OF TISSUES BY MASS SPECTROMETRY: LOOKING BEYOND THE MICROSCOPE
    Caprioli, Richard
    DRUG METABOLISM REVIEWS, 2012, 44 : 10 - 11
  • [9] Role of Lipids in the Pathogenesis of Parkinson's Disease
    Kamano, Shumpei
    Ozawa, Daisaku
    Ikenaka, Kensuke
    Nagai, Yoshitaka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [10] Molecular landscape of Parkinson's disease reveals a key role for lipids and lipoproteins
    Klemann, C. J. H. M.
    Martens, G. J. M.
    Sharma, M.
    Martens, M. B.
    Isacson, O.
    Gasser, T.
    Visser, J. E.
    Poelmans, G.
    MOVEMENT DISORDERS, 2016, 31 : S280 - S280